Karthik Subramaniam, Manoj P Joseph, Lakshmi A Babu
{"title":"A Common Drug Causing a Common Side Effect at an Uncommon Time: Metformin-Induced Chronic Diarrhea and Weight Loss After Years of Treatment.","authors":"Karthik Subramaniam, Manoj P Joseph, Lakshmi A Babu","doi":"10.2337/cd20-0101","DOIUrl":null,"url":null,"abstract":"Type 2 diabetes is a common condition, with a worldwide prevalence of 9.3% as of 2019 (1). Metformin is the most common drug used and is the first-line agent in type 2 diabetes management. It is also considered one of the safest pharmacological agents for the treatment of the disease. However, gastrointestinal side effects are common, occurring in up to 75% of those who takemetformin (2). These side effects may include diarrhea, nausea, vomiting, abdominal discomfort, and/or flatulence, with severity ranging from mild to severe. These complications are more common with immediate-release preparations of metformin than with its extended-release formulation. Discontinuation and nonadherence rates have been as high as 46% with metformin because of these issues (3).","PeriodicalId":519493,"journal":{"name":"Clinical Diabetes : A Publication of the American Diabetes Association","volume":"39 2","pages":"237-240"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061542/pdf/diaclincd200101.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes : A Publication of the American Diabetes Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/cd20-0101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Type 2 diabetes is a common condition, with a worldwide prevalence of 9.3% as of 2019 (1). Metformin is the most common drug used and is the first-line agent in type 2 diabetes management. It is also considered one of the safest pharmacological agents for the treatment of the disease. However, gastrointestinal side effects are common, occurring in up to 75% of those who takemetformin (2). These side effects may include diarrhea, nausea, vomiting, abdominal discomfort, and/or flatulence, with severity ranging from mild to severe. These complications are more common with immediate-release preparations of metformin than with its extended-release formulation. Discontinuation and nonadherence rates have been as high as 46% with metformin because of these issues (3).